Hints and tips:
Related Special Reports
...“Like consumer and business audiences, authentic credibility has overtaken hard sales when it comes to increasing trust and business growth,” he added....
...He chairs consumer health group Haleon and was instrumental in reviving Tesco’s fortunes during his tenure after an accounting scandal in 2014....
...GSK has announced plans to sell down its stake in consumer health company Haleon, selling about 2.9 per cent of the Panadol maker’s issued share capital....
...Last year Haleon, which manufactures consumer health goods including Sensodyne toothpaste and Panadol painkillers, sold athlete’s foot cream brand Lamisil to Sweden’s Karo Healthcare for £235mn....
...J&J has been sitting on a significant cash pile after it decided to spin out its consumer health business Kenvue last year, with the share offering generating $13.2bn....
...The company has been working with the pharmaceutical giant GSK, focusing on immuno-oncology drugs....
...’s consumer health division....
...It also completed the $2bn acquisition of Bellus Health, adding a speciality medicine for a debilitating and persistent cough....
...Haleon, GSK’s consumer health division which was spun out last year and which manufactures products such as Panadol painkillers and Sensodyne toothpaste, also announced it would shift to a third-party distribution...
...BUY: GSK (GSK) Sceptics will say the pipeline leaves much to be desired, but there’s no denying the drugmaker’s present strengths, writes Jennifer Johnson....
...A US appeals court has allowed a sales ban on Apple’s Watch Series 9 and Ultra 2 to resume, the latest setback in the technology giant’s dispute with health technology company Masimo over patents for its...
...“We’re positioning the company for the long-term health of the business and the market doesn’t necessarily operate that way,” she said....
...Investors were dismayed by the failed £50bn bid for GSK’s consumer healthcare arm, now Haleon, early last year....
...Johnson & Johnson spun off consumer health unit Kenvue this year while GSK and Pfizer combined their consumer businesses to create Haleon in 2019....
...Brussels blocked the deal a year later over concerns it would limit consumer choice and hurt innovation. Illumina appealed to the EU court but it sided with the commission in 2022....
...Five years ago 23andMe partnered with GSK. It has some 50 programmes under way. If it can monetise just one it would transform the entire business....
...But Haleon, the consumer health group spun off from GSK, also features. Both its major owners, GSK and Pfizer, have placed large chunks of stock in the market in recent months....
...Manufacturers of consumer health products have been more resilient to down-trading than other consumer categories during the cost of living crisis....
...Investors had wiped a combined £30bn from the valuations of GSK, its consumer spin-off Haleon, Sanofi and Pfizer over two days in August last year over fears about lawsuits related to Zantac, and the size...
...Apple is resuming sales in the US of its Watch Series 9 and Ultra 2 after an appeals court halted a ban handed down by a trade tribunal, the latest development in an ongoing patent battle with health technology...
...GSK is buying Canadian biotech Bellus Health in a £1.6bn deal, the UK drugmaker’s largest acquisition since it spun off its consumer health division last year....
...Efforts to aid recuperation intensified on Tuesday with news of its $2bn acquisition of Canadian biotech Bellus Health. The consumer spin-off freed up about £7bn of capital....
...Unilever has been criticised for a period of disappointing performance over the past decade, as well as for its acquisition mis-steps, including its botched bid for GSK and Pfizer’s consumer health division...
...GSK rejected the offer in January 2022, claiming it “fundamentally undervalued” the consumer health unit....
...In addition, the rules cap discounts that retailers can give on health, beauty and hygiene products to 34 per cent....
International Edition